Clostridium difficile infection in patients with chronic pancreatitis was associated with more comorbidities, greater mortality risk, longer hospital stays and higher health care costs, compared with patients without CDI, according to a study led by Himanshu Kavani, MD, of St. Mary Medical Center in Pennsylvania and presented at ACG's 2020 Annual Virtual Scientific Meeting. Comorbidities identified in the study included diabetes, liver diseases, renal failure, weight loss, fluid and electrolyte disorders, and coagulopathy.
CDI with pancreatitis linked to comorbidities, mortality
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.